Compound Radar

Teleflex Incorporated (TFX) Stock Analysis

Price $139.00
Market cap $5.89B
Next earnings Nov 5, 2026
Entry status Wait

Last updated Oct 27, 2026

Health Check

Last analyzed Oct 23, 2026

51
51/100 Speculative
  • Financial Health 50
  • Profitability 50
  • Business Quality 75
  • Balance Sheet 30
  • Cash Flow 45

Why this rating?

Health 51/100 — Speculative

Strongest Business Quality 75/100
Softest Balance Sheet 30/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Teleflex Incorporated (TFX) is a Medical Instruments & Supplies company in the Healthcare sector. Compound Radar rates Teleflex Incorporated 51/100 (Speculative) due to high business quality, strong revenue growth, and elevated leverage.

Investment profile

  • Quality High
  • Growth Strong
  • Balance Sheet Stretched
  • Valuation Attractive

Financial highlights

Valuation

  • Forward P/E 12.7
  • PEG 0.16
  • EV/Revenue 3.73

Profitability

  • Revenue Growth 28.9%
  • Gross Margin 55.1%
  • Operating Margin 10.1%
  • Net Margin -45.8%
  • ROE -0.7%

Financial strength

  • Cash $323.94M
  • Debt $2.94B
  • Net Cash $-2.61B
  • Free Cash Flow $245.44M
  • Current Ratio 2.6

Similar companies

Peers in Medical Instruments & Supplies, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Instruments & Supplies →

FAQ

How Compound Radar scores and tracks Teleflex Incorporated (TFX).

View Methodology & FAQ →